Slotwiner D, Varma N, Akar JG, Annas G, Beardsall M, Fogel RI, Galizio NO, Glotzer TV, Leahy RA, Love CJ, Mclean RC, Mittal S, Morichelli L, Patton KK, Raitt MH, Ricci RP, Rickard J, Schoenfeld MH, Serwer GA, Shea J, Varosy P, Verma A, Yu CM. HRS expert c Heart Rhythm 12: e69-e100. 2015.
Varma N, Piccini JP, Snell J, Fischer A, Dalal N, Mittal S. The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol 65:2601-2610. 2015.
Ghosh S, Stadler RW, Mittal S. Automated detection of effective left ventricular pacing: Going beyond percentage pacing counters. Europace doi:10.1093/europace/euv062. 2015.
Mittal S, Aktas M, Moss AJ, McNitt S, Kutyifa V, Steinberg JS, Zareba W. The impact of non-sustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT (Multicenter Automatic Implantation Trial-cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol doi: 10.1111/jce.12456. 2014.
Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, Preminger M, Sichrovsky T, Steinberg JS. Cardiac implantable electronic device infections: Incidence, risk factors, and the effect of the AigisRX antibacterial envelope. Heart Rhythm 11: 595-601. 2014.
Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads (NAVIGATE X4)
(PRAETORIAN) A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy
I am the United States national PI for the PRAETORIAN trial. The aim of this trial is to assess the advantages and disadvantages of the subcutaneous implantable cardioverter defibrillator (ICD) compared to the transvenous ICD.
World-wide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT)
I am on the Steering Committee of the WRAP-IT trial. The aim of this trial is to evaluate the ability of the TYRX antimicrobial envelope to reduce major cardiac implantable electronic device (CIED) infections through 12-months post-procedure following CIE